Please wait...
Share Wealth
Home
Services
Research
Market
News
Download
Inviting Business Associates
Profile
Careers
Contact Us
Login
Open An Account
Copyright © 2010
Sharewealth Group of Companies.
Designed & Developed by
<
>
Market
Equity
Overview
Top Gainers
Top Losers
Top Volume
Top Value
Close Prices
52 Week High/Low
Indices
ADR-GDR Prices
Advance Decline
Forex
Holiday List
Market Commentary
DERIVATIVES
Derivatives Home
Top Gainers
Top Losers
Top Traded Volume
Top Traded Value
Highest in Premium
Most Active Calls
Most Active Puts
Most Active Contracts
Open Interest
Historical Data
FII Statistics
Get Quotes All
Get Quotes
Settlement Prices
Put Call Ratio
Underlying Info
Active Underlying Info
COMMODITY
Overview
Top Gainers
Top Losers
Top Volume
Top Value
Highest in OI
Lowest in OI
Increase in OI
Decrease in OI
Spot Gainers/Losers
Advances Declines
Market Breadth
Commodity News
Closing Prices
Search
Commodity Indices
IPO
Overview
Issue Profiles
Forthcoming IPO
Open Issues
Closed Issues
New Listing
IPO News
Basis of Allotment
Draft Prospectus
Comparative Study
MUTUAL FUND
MF Home
MF Gainers
MF Losers
Latest NAV
Forthcoming Issues
MF Open Issues
MF Closed Issues
Fund Mobilization
MF Activity
MF News
MF FAQs
Scheme Search
Scheme Profile
ANNOUNCEMENT
BSE Announcements
NSE Announcements
Board Meetings
Change of Company Names
AGM Details
Dividend Details
Bonus Details
Rights Details
Splits Details
Delisted Shares
FII Activity
MF Activity
My Easy Will
Markets Navigation
Equity
Derivatives
Company Info.
IPO
Announcement
Commodity
Mutual Fund
Currency
Company Info.
Live Quotes
Company Profile
Locations
Shareholding Pattern
Products & Raw Material
Management Team
Director's Report
Company News
Income Statement
Balance Sheet
Ratios Analysis
Cash Flow
High Low
Technical Charting
Company Meetings
Investor Returns
Jubilant Pharmova Ltd.
Live Quotes
Registered Address
Registered Office : Bhartiagram, Gajraula,
Amroha District, Uttar Pradesh - 244223
Tel: 05924-267437
Fax: 05924-252352
Email :
investors@jubl.com
Website :
http://www.jubilantpharmova.com
Key Officials
Name
Designation
Mr. Naresh Kapoor
Co. Secretary & Compl. Officer
Mr. Shantanu Jha
Group Chief Human Resources Officer
Dr. Saji Thomas
Vice President & Head
Listings
BSE , MCXSX , NSE
Corporate News
Jubilant Pharmova - Disclosure under SEBI Takeover Regulatio...
Jubilant Pharmova - General Updates
Jubilant Pharmova - Trading Window-XBRL
Jubilant Pharmova - Trading Window
Jubilant Pharmova - General Updates
Jubilant Pharmova - General Updates
Jubilant Pharmova - Announcement Under Regulation 30 - USFDA...
Jubilant Pharmova - Analysts/Institutional Investor Meet/Con...
Jubilant Pharmova - Rumour Verification - Regulation 30(11)
Jubilant Pharmova - Rumour verification - Regulation 30(11)
Board Meetings
Date
Purpose
31/01/2025
Quarterly Results
25/10/2024
Quarterly Results
19/07/2024
Quarterly Results
Share Holding Pattern as on 31/12/2024
Major Holder
No. of Shares
Percentage(%)
Promoters
80,717,056
50.68
Institutional Investors
38,127,887
23.94
Other Investors
11,620,750
7.30
General Public
28,815,446
18.09
Registrar Details
Alankit Assignment Ltd.
205-208, Anarkali Complex, Jhandewalan Extension
New Delhi,110055,Delhi
Tel :
011-42541954
Fax :
41543474
Today's Market
BSE
Market Performance
Exchange
BSE
NSE
Last Traded Price (
`
)
957.45
958.10
Last Traded Date
04/04/2025
04/04/2025
Last Traded Time
09:36:00 AM
09:24:56 AM
Change (%)
-1.46%
-1.28%
Day's Open (
`
)
971.65
974.70
Previous Close (
`
)
971.65
970.55
Day's High (
`
)
973.70
974.70
Day's Low (
`
)
956.55
955.20
Total Traded Qty
2594
33659
Value (
`
In Lacs)
24.84
324.50
Bid Price (
`
)
959.65
958.15
Bid Quantity
8
13
Offer Price (
`
)
962.05
958.85
Offer Quantity
4
1
Exchange Code
530019
JUBLPHARMAEQ
Exchange Group
A
OtherEQ
Jubilant Pharmova Ltd.
Company Profile
JUBILANT PHARMOVA LTD.
Market Cap.(
`
)
15260.73 Cr.
P/BV
2.57
Book Value (
`
)
372.96
52 Week High/Low (
`
)
1310/576
FV/ML
1/1
P/E(X)
197.94
Book Closure
02/08/2024
EPS (
`
)
4.84
Div Yield (%)
0.52
Registered Office
Registered Office : Bhartiagram, Gajraula,,
Amroha District, Uttar Pradesh - 244223
Tel: 05924-267437,Fax: 05924-252352
Website :
http://www.jubilantpharmova.com
Email :
investors@jubl.com
Registrar & Share Transfer Agent
Alankit Assignment Ltd.
205-208, Anarkali Complex, Jhandewalan Extension, , , New Delhi - 110055, Delhi
Tel : 011-42541954, 42541234 Fax : 41543474
Recent News
Headline
Date
Jubilant Pharmova - Disclosure under SE...
02/04/2025
Jubilant Pharmova - General Updates
25/03/2025
Jubilant Pharmova - Trading Window-XBRL
24/03/2025
Jubilant Pharmova - Trading Window
24/03/2025
View More
Other Details
Business Group
Bhartia Group
BSE Code
530019
NSE Code
JUBLPHARMAEQ
Listings
BSE , MCXSX , NSE
ISIN No.
INE700A01033
Attention Investors :
“Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. |
"Revised guidelines on margin collection
==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI :
https://scores.gov.in/scores/Welcome.html
Investor Protection
BSE
NSE
MCX
Investor Safeguards
BSE
NSE
MCX
Disclaimer